MTF Biologics and Kolosis BIO have launched DBX Fiber, a new demineralized bone matrix product designed for complex spinal and orthopaedic procedures. The fibre tissue form is processed to provide surgeons with enhanced handling and osteoinductive potential in challenging fusion environments. DBX Fiber expands the existing DBX portfolio, which already includes DBX Mix and DBX Putty. The addition strengthens Kolosis' surgical biologics portfolio, which features products such as Kore Fiber, a cortical bone allograft, and Summit Matrix, a synthetic bone graft. MTF Biologics is a global nonprofit organisation focused on tissue and organ donation, transplantation and research. Kolosis BIO specialises in commercialising surgical biologics technologies across spine and orthopaedic procedures. The partnership aims to provide surgeons with greater versatility whilst maintaining trusted biologics solutions.

MTF Biologics, a global nonprofit tissue and organ donation organisation, and Kolosis BIO have launched Summit Matrix, an advanced synthetic bone graft for orthopedic and spinal surgeries. The product uses NanoLift surface technology, combining nanoscale topography with biomimetic chemistry to enhance bone regeneration. Summit Matrix integrates with existing products including Kore Fiber, Prime HD and DBX Mix. Its hydroxycarbanoapatite composition mimics natural bone mineral, enabling optimal resorption and osseointegration. The nanocrystalline surface supports cell activity to promote bone formation. The launch expands the partnership between MTF Biologics, founded by orthopedic surgeons nearly 40 years ago, and Kolosis BIO, which has established itself as a leading orthobiologics provider. Together, the organisations aim to deliver innovative solutions that enhance surgical efficiency and clinical practice.

Dr. Mia Talmor, Professor of Clinical Surgery at The Weill Cornell Medical School and attending surgeon at New York Presbyterian Hospital, has joined the MTF Biologics Board of Directors. (Photo: Business Wire)Dr. Mia Talmor, Professor of Clinical Surgery at The Weill Cornell Medical School and attending surgeon at New York Presbyterian Hospital, has joined the MTF Biologics Board of Directors. (Photo: Business Wire)EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, has announced the appointment of Mia Talmor, MD, to the MTF Biologics Board of Directors.“We are honored to welcome Dr. Talmor to the MTF Board,” said William W